Volume 62, Issue 1, Pages (July 2002)

Slides:



Advertisements
Similar presentations
Volume 68, Issue 4, Pages (October 2005)
Advertisements

Volume 54, Issue 2, Pages (August 1998)
Volume 62, Issue 5, Pages (November 2002)
Lakhmir S. Chawla, Paul L. Kimmel  Kidney International 
Volume 94, Issue 3, Pages (September 2018)
Volume 61, Issue 2, Pages (February 2002)
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
Volume 68, Issue 6, Pages (December 2005)
Health care utilization among patients with chronic kidney disease
Stem cells for kidney repair: useful tool for acute renal failure?
The Case ∣ Acute renal failure and anemia
Volume 74, Issue 10, Pages (November 2008)
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Volume 82, Issue 8, Pages (October 2012)
Actin cytoskeleton in ischemic acute renal failure
Ralph Witzgall, Bettina Kränzlin, Norbert Gretz, Nicholas Obermüller 
Volume 56, Issue 5, Pages (November 1999)
Volume 60, Issue 1, Pages (July 2001)
Volume 70, Issue 12, Pages (December 2006)
Volume 73, Issue 4, Pages (February 2008)
αvβ6 integrin expression in diseased and transplanted kidneys
Volume 68, Issue 4, Pages (October 2005)
Volume 76, Issue 2, Pages (July 2009)
Volume 53, Issue 4, Pages (April 1998)
Role of meprin A in renal tubular epithelial cell injury
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Richard A. Zager, Ali C.M. Johnson, Sherry Y. Hanson 
Gregory B. Vanden Heuvel  Kidney International 
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Volume 72, Issue 8, Pages (October 2007)
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 66, Issue 6, Pages (December 2004)
Volume 76, Issue 3, Pages (August 2009)
Volume 54, Issue 2, Pages (August 1998)
Volume 76, Issue 10, Pages (November 2009)
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Volume 56, Issue 4, Pages (October 1999)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 68, Issue 1, Pages (July 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 73, Issue 5, Pages (March 2008)
Volume 63, Issue 5, Pages (May 2003)
The L1 cell adhesion molecule is a potential biomarker of human distal nephron injury in acute tubular necrosis  Y. Allory, V. Audard, P. Fontanges, P.
Volume 61, Issue 1, Pages (January 2002)
Volume 60, Issue 6, Pages (December 2001)
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells  Gur P. Kaushal, Varsha Kaushal, Ph.D., Xiaoman.
Volume 77, Issue 8, Pages (April 2010)
Urinary biomarkers: the future looks promising
Volume 74, Issue 8, Pages (October 2008)
Volume 73, Issue 3, Pages (February 2008)
Volume 60, Issue 6, Pages (December 2001)
Volume 54, Issue 5, Pages (November 1998)
Volume 78, Issue 5, Pages (September 2010)
Babu J. Padanilam, Andrew J.P. Lewington, Marc R. Hammerman 
Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease  Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,
Volume 64, Pages S52-S56 (October 2003)
Volume 65, Issue 6, Pages (June 2004)
Volume 67, Issue 4, Pages (April 2005)
Urinary biomarkers in the early diagnosis of acute kidney injury
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Volume 64, Issue 1, Pages (July 2003)
Inflammatory cells in ischemic acute renal failure
Increased importin α protein expression in diabetic nephropathy
Volume 80, Issue 10, Pages (November 2011)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Volume 64, Issue 2, Pages (August 2003)
Richard A. Zager, Ali Johnson, Sherry Hanson, Vivian Dela Rosa 
Lipoprotein abnormalities in diabetic nephropathy
Volume 55, Issue 5, Pages (May 1999)
Volume 79, Issue 10, Pages (May 2011)
Presentation transcript:

Volume 62, Issue 1, Pages 237-244 (July 2002) Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury  Won K. Han, Veronique Bailly, Rekha Abichandani, Ravi Thadhani, Joseph V. Bonventre  Kidney International  Volume 62, Issue 1, Pages 237-244 (July 2002) DOI: 10.1046/j.1523-1755.2002.00433.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 KIM-1 expression in a normal human kidney (A) and one with acute tubular necrosis; (B) human kidney paraffin sections are stained for KIM-1 using the AKG7 anti-human KIM-1 monoclonal antibody, and an ABC peroxidase detection system with DAB substrate (Vector). Normal kidney tissue was taken from a patient with renal cell carcinoma. Kidney International 2002 62, 237-244DOI: (10.1046/j.1523-1755.2002.00433.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Western blot analysis of urine collected from patients with different forms of renal failure. Each lane represents protein immunoextracted from urines of patients without renal disease, with ischemic ATN, other forms of ARF (prerenal azotemia, contrast nephropathy, post-renal), or chronic diseases (systemic lupus erythematosus nephropathy, SLE; diabetic nephropathy, DM). After immunoextraction and PAGE, Western blot analysis was carried out with the AKG7 anti-KIM-1 antibody. Kidney International 2002 62, 237-244DOI: (10.1046/j.1523-1755.2002.00433.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Comparison of urinary KIM-1 concentration in various forms of renal diseases. Scatterogram of absolute KIM-1 concentration is shown to discriminate the value of KIM-1 among the different groups of patients. Number of patients in each group is indicated above the scatterogram. Values shown are means ±(SE). Abbreviations are: ATN, acute tubular necrosis; Other ARF, acute renal failure with causes other than ischemia and contrast nephropathy. Kidney International 2002 62, 237-244DOI: (10.1046/j.1523-1755.2002.00433.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 KIM-1 expression in urine of patient after abdominal aortic aneurysm repair. Time course of KIM-1 expression in urine of a patient who underwent an elective repair of an abdominal aortic aneurysm. Sequential urine samples were collected every 6 hours from the onset of operation. Urine sediment was checked at every time point KIM-1 was measured. Kidney International 2002 62, 237-244DOI: (10.1046/j.1523-1755.2002.00433.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Comparison of KIM-1 and other urinary proteins as biomarkers for tubule injury in various renal diseases. Urinary alkaline phosphatase, γ-glutamyltransferase, (γGT) and total protein were measured for comparison with urine KIM-1 as markers for ATN. Number of patients in each group is indicated above the top bars. Urinary biomarker concentrations are normalized to urine creatinine concentration. Kidney International 2002 62, 237-244DOI: (10.1046/j.1523-1755.2002.00433.x) Copyright © 2002 International Society of Nephrology Terms and Conditions